Colgate-Palmolive Company

(New York Stock Exchange)
Back to all articles
Bullish +65

Colgate-Palmolive (NYSE:CL) Stock Price Expected to Rise, UBS Group ...

AI-generated analysis

πŸ“ˆ UBS Group raised its price target on Colgate-Palmolive from $100.00 to $106.00, projecting a 14.17% upside potential.

πŸ“Š The company reported quarterly EPS of $0.97, beating the consensus estimate of $0.94 by $0.03.

πŸ’° Revenue for the quarter reached $5.32 billion, exceeding analyst expectations of $5.22 billion.

πŸ“ˆ Year-over-year revenue growth was recorded at 8.4% during the reported quarter.

🏦 Return on equity stood at 386.76% with a net margin of 10.04% for the period.

πŸ‘” HighPoint Advisor Group LLC increased its holdings by 0.7% to own 15,877 shares valued at $1.255 million.

πŸ“‰ Clear Harbor Asset Management LLC lifted its position by 2.6% to hold 4,503 shares worth $356,000.

πŸ›οΈ Institutional and hedge fund ownership of the stock remains high at 80.41%.

πŸ“‰ Wall Street Zen downgraded the stock from 'buy' to 'hold' in a recent research report.

🎯 The average analyst price target across twelve buy and seven hold ratings is $97.41.

Bullish Signals
  • UBS Group increased its price target by $6.00 to $106.00, indicating a bullish outlook with 14.17% upside potential.
  • Colgate-Palmolive beat quarterly earnings expectations with EPS of $0.97 compared to the consensus of $0.94.
  • Revenue of $5.32 billion exceeded analyst forecasts of $5.22 billion, demonstrating strong top-line performance.
  • The company achieved an 8.4% year-over-year revenue increase, signaling robust business growth.
  • HighPoint Advisor Group LLC and Clear Harbor Asset Management LLC both increased their holdings in the fourth quarter.
  • Institutional ownership stands at 80.41%, reflecting continued confidence from major investors and hedge funds.
  • Citigroup raised its price target to $110.00 with a 'buy' rating, adding to the positive analyst sentiment.
Full Analysis
UBS Group raised its price target on Colgate-Palmolive (NYSE:CL) from $100.00 to $106.00, citing a potential upside of 14.17% from the previous close, while maintaining a 'buy' rating. This follows a series of analyst actions including Wells Fargo increasing its target to $95.00 with an 'equal weight' rating and Citigroup raising its target to $110.00 with a 'buy' rating. Conversely, Wall Street Zen downgraded the stock from 'buy' to 'hold', resulting in a consensus average target price of $97.41 based on ratings from twelve buy analysts and seven hold analysts. The company recently reported quarterly earnings for the quarter ended May 1st, beating analyst expectations with EPS of $0.97 versus a consensus of $0.94. Revenue reached $5.32 billion, surpassing the expected $5.22 billion, representing an 8.4% year-over-year increase. Key financial metrics included a return on equity of 386.76% and a net margin of 10.04%, with analysts forecasting an average EPS of $3.81 for the current year. Institutional ownership remains strong at 80.41%, with several major investors increasing their stakes in the fourth quarter. HighPoint Advisor Group LLC grew its holdings by 0.7% to own 15,877 shares valued at $1.255 million, while Clear Harbor Asset Management LLC increased its position by 2.6% to hold 4,503 shares worth $356,000. Other active investors include Moneta Group Investment Advisors LLC and Cooper Financial Group, which boosted their positions by 0.7% and 4.0% respectively.